ethyl 4-(naphthalen-1-yloxy)-3-oxobutanoate, 95.0%, 2g

TERT-BUTYL (2S)-2-(AMINOMETHYL)-2-ETHYLPYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 10g

2-Amino-5-chlorobenzoxazole, 97.0%, 10g

2-(BROMOMETHYL)-1-FLUORO-4-METHOXYBENZENE, 95.0%, 500mg

Cyclohexanol, min. 99%, for synthesis, 1L, glass packaging

Imidazol-1-yl-acetic acid, 99.00%, 1g

n-(2-Hydroxypropyl)acetamide, 97%, 2.5g

Spiro[3.4]Octan-1-ol, 98%, 500mg

[1,1'-Binaphthalen]-2-yldi-tert-butylphosphine, 95.0%, 1g

1-Bromo-9H-fluoren-9-one, 98%, 5g

4-(2-oxopyrrolidin-1-yl)benzenesulfonamide, 1g

4-Hydroxy-3-nitrocoumarin>98.0%(HPLC)(T)5g